Up to 40% of people who suffer from depression are unable to find any relief for their condition. But now, Blessing ...

Esketamine is J&J's patented version of ketamine, a dissociative anesthetic with psychedelic properties that was first synthesized in 1962. Numerous scientific studies have demonstrated ketamine's ...

Yesterday, the drugmaker added to the evidence behind Spravato – an intranasal formulation of esketamine – with the release of top-line data from a head-to-head study with a long-acting ...

Esketamine, the S isomer of ketamine, has already gained approval for treatment-resistant depression under the trademark Spravato; psilocybin and ketamine have been shown to provide benefits to ...

The pharmaceutical company Johnson & Johnson created the spray from esketamine, a more potent version of ketamine. Esketamine should only provide rapid relief from depression symptoms until other ...

Rao cited Johnson & Johnson's Spravato (esketamine), a hallucinogen drug closely related to ketamine, as an example of a therapy the FDA has approved that has mood-altering properties. Esketamine ...

The Daily Gate mobile app brings you the latest local breaking news, updates, and more. Read the Daily Gate on your mobile device just as it appears in print.

I provide outpatient psychiatric evaluations, medication management, supportive therapy, (GeneSight) pharmacogenomic testing, and Esketamine/Spravato treatments. Promoting a safe environment for ...

There is hope for your symptoms. The clinic also offer the FDA approved Spravato (Esketamine) for treatment resistant depression, anxiety, and PTSD. Call for inquiries. Immediate appointment times ...